Search Results

Filter
  • 1-8 of  8 results for ""Bone Morphogenetic Protein Receptors, Type II""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

LncRNA MYOSLID contributes to PH via targeting BMPR2 signaling in pulmonary artery smooth muscle cell.

  • Authors : Chen Y; Wuxi Lung Transplant Center, Department of Thoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, 299 Qingyang Road, Wuxi 214023, Jiangsu, China.; Li Y

Subjects: Pulmonary Artery*/Pulmonary Artery*/Pulmonary Artery*/metabolism ; Pulmonary Artery*/Pulmonary Artery*/Pulmonary Artery*/pathology ; Pulmonary Artery*/Pulmonary Artery*/Pulmonary Artery*/drug effects

  • Source: Vascular pharmacology [Vascul Pharmacol] 2024 Dec; Vol. 157, pp. 107439. Date of Electronic Publication: 2024 Nov 15.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130615 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling.

  • Authors : Wang J; Department of Pharmacology, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410008, China; Department of Clinical Pharmacy, First People's Hospital of Huaihua, Huaihua 418000, China.

Subjects: Arterial Pressure*/Arterial Pressure*/Arterial Pressure*/drug effects; Bone Morphogenetic Protein Receptors, Type II/Bone Morphogenetic Protein Receptors, Type II/Bone Morphogenetic Protein Receptors, Type II/*metabolism ; HMGB1 Protein/HMGB1 Protein/HMGB1 Protein/*metabolism

  • Source: Vascular pharmacology [Vascul Pharmacol] 2019 Jun; Vol. 117, pp. 35-44. Date of Electronic Publication: 2019 Jan 03.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130615 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The BMP type II receptor is located in lipid rafts, including caveolae, of pulmonary endothelium in vivo and in vitro.

  • Authors : Ramos M; Department of Veterinary Medicine: Pathology, Immunology, Microbiology, One Shields Avenue, 1044 Haring Hall, University of California, Davis, Davis, California 95616-8617, United States. ; Lamé MW

Subjects: Bone Morphogenetic Protein Receptors, Type II/Bone Morphogenetic Protein Receptors, Type II/Bone Morphogenetic Protein Receptors, Type II/*analysis ; Caveolae/Caveolae/Caveolae/*metabolism ; Endothelium, Vascular/Endothelium, Vascular/Endothelium, Vascular/*metabolism

  • Source: Vascular pharmacology [Vascul Pharmacol] 2006 Jan; Vol. 44 (1), pp. 50-9. Date of Electronic Publication: 2005 Nov 03.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130615 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
Academic Journal

SEMA3G regulates BMP9 inhibition of VEGF-mediated migration and network formation in pulmonary endothelial cells.

  • Authors : Mirza SL; Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge CB2 0BB, UK; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK.

Subjects: Cell Movement*/Cell Movement*/Cell Movement*/drug effects ; Semaphorins*/Semaphorins*/Semaphorins*/metabolism ; Semaphorins*/Semaphorins*/Semaphorins*/genetics

  • Source: Vascular pharmacology [Vascul Pharmacol] 2024 Jun; Vol. 155, pp. 107381. Date of Electronic Publication: 2024 May 23.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130615 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Inflammation in pulmonary artery hypertension.

  • Authors : Sakuma M; Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Tochigi 321-0293, Japan. Electronic address: .; Toyoda S

Subjects: Arterial Pressure*/Arterial Pressure*/Arterial Pressure*/drug effects ; Vascular Remodeling*/Vascular Remodeling*/Vascular Remodeling*/drug effects; Hypertension, Pulmonary/Hypertension, Pulmonary/Hypertension, Pulmonary/*metabolism

  • Source: Vascular pharmacology [Vascul Pharmacol] 2019 Jul - Aug; Vol. 118-119, pp. 106562. Date of Electronic Publication: 2019 May 18.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130615 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

MnTBAP increases BMPR-II expression in endothelial cells and attenuates vascular inflammation.

  • Authors : Zhou Q; Department of Cardiology and Angiology I, Heart Center, Medical Faculty, University of Freiburg, Freiburg, Germany.; Einert M

Subjects: Anti-Inflammatory Agents/Anti-Inflammatory Agents/Anti-Inflammatory Agents/*pharmacology ; Inflammation/Inflammation/Inflammation/*drug therapy ; Metalloporphyrins/Metalloporphyrins/Metalloporphyrins/*pharmacology

  • Source: Vascular pharmacology [Vascul Pharmacol] 2016 Sep; Vol. 84, pp. 67-73. Date of Electronic Publication: 2016 Jul 08.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130615 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Interaction between bone morphogenetic proteins and endothelin-1 in human pulmonary artery smooth muscle.

  • Authors : Din S; Imperial College London, Heart Science Centre, Harefield Hospital, Harefield, Middlesex, UB9 6JH, United Kingdom.; Sarathchandra P

Subjects: Bone Morphogenetic Proteins/Bone Morphogenetic Proteins/Bone Morphogenetic Proteins/*physiology ; Endothelin-1/Endothelin-1/Endothelin-1/*physiology ; Muscle, Smooth, Vascular/Muscle, Smooth, Vascular/Muscle, Smooth, Vascular/*physiology

  • Source: Vascular pharmacology [Vascul Pharmacol] 2009 Nov-Dec; Vol. 51 (5-6), pp. 344-9. Date of Electronic Publication: 2009 Sep 26.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130615 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Monocrotaline pyrrole induces Smad nuclear accumulation and altered signaling expression in human pulmonary arterial endothelial cells.

  • Authors : Ramos M; Department of Veterinary Medicine, Pathology, Immunology, Microbiology, University of California, Davis, Davis, California 95616, USA.; Lamé MW

Subjects: Alkylating Agents/Alkylating Agents/Alkylating Agents/*toxicity ; Cell Nucleus/Cell Nucleus/Cell Nucleus/*drug effects ; Endothelial Cells/Endothelial Cells/Endothelial Cells/*drug effects

  • Source: Vascular pharmacology [Vascul Pharmacol] 2007 Jun; Vol. 46 (6), pp. 439-48. Date of Electronic Publication: 2007 Feb 02.Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130615 Publication Model: Print-Electronic Cited Medium: Print ISSN:

Record details

×
  • 1-8 of  8 results for ""Bone Morphogenetic Protein Receptors, Type II""